Loading...

Tina Bhutani-Jacques, MD

Title(s)Assistant Professor, Dermatology
SchoolSchool of Medicine
Phone415-353-7800
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoCert2011 Medicine (Advance Training in Clinical Research)

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Harirchian P, Lee J, Hilz S, Sedgewick AJ, Perez White BE, Kesling MJ, Mully T, Golovato J, Gray M, Mauro TM, Purdom E, Kim EA, Sbitany H, Bhutani T, Vaske CJ, Benz SC, Cho RJ, Cheng JB. A20 and ABIN1 suppression of a keratinocyte inflammatory program with a shared single cell expression signature in diverse human rashes. J Invest Dermatol. 2018 Dec 10. PMID: 30543901.
      View in: PubMed
    2. Yang EJ, Beck KM, Bhutani T, Feldman SR, Shi VY. Pharmacy costs of systemic medications for hidradenitis suppurativa in the United States. J Dermatolog Treat. 2018 Nov 19; 1-3. PMID: 30256691.
      View in: PubMed
    3. Beck KM, Yang EJ, Sekhon S, Bhutani T, Liao W. Dupilumab Treatment for Generalized Prurigo Nodularis. JAMA Dermatol. 2018 Nov 14. PMID: 30427994.
      View in: PubMed
    4. Lee EB, Wu KK, Lee MP, Bhutani T, Wu JJ. Psoriasis risk factors and triggers. Cutis. 2018 Nov; 102(5S):18-20. PMID: 30566552.
      View in: PubMed
    5. Yang EJ, Sekhon S, Sanchez IM, Beck KM, Bhutani T. Recent Developments in Atopic Dermatitis. Pediatrics. 2018 Oct; 142(4). PMID: 30266868.
      View in: PubMed
    6. Amin M, Lee EB, Bhutani T, Wu JJ. Review of European registries for psoriasis. J Dermatolog Treat. 2018 Sep 14; 1-10. PMID: 30051739.
      View in: PubMed
    7. Beck KM, North JP, Bhutani T. Progressive Hyperpigmented Plaques: Challenge. Am J Dermatopathol. 2018 Jul 24. PMID: 30045069.
      View in: PubMed
    8. Yang EJ, Beck KM, Sekhon S, Bhutani T. Pharmacy costs of specialty medications for plaque psoriasis in the United States. J Am Acad Dermatol. 2019 Jan; 80(1):274-275. PMID: 29673778.
      View in: PubMed
    9. Yang EJ, Sanchez IM, Beck K, Sekhon S, Wu JJ, Bhutani T. Guselkumab for the treatment of moderate-to-severe plaque psoriasis. Expert Rev Clin Pharmacol. 2018 Apr; 11(4):333-344. PMID: 29478344.
      View in: PubMed
    10. Amin M, Lee EB, Bhutani T, Wu JJ. Do psoriasis patients engage in vigorous physical activity? Cutis. 2018 Mar; 101(3):198-200. PMID: 29718018.
      View in: PubMed
    11. Lee EB, Amin M, Bhutani T, Wu JJ. Emerging therapies in psoriasis: a systematic review. Cutis. 2018 Mar; 101(3S):5-9. PMID: 29718027.
      View in: PubMed
    12. Yang EJ, Sekhon S, Beck KM, Bhutani T, Koo J. Neuromodulation in Inflammatory Skin Disease. Dermatol Ther (Heidelb). 2018 Mar; 8(1):1-4. PMID: 29427206.
      View in: PubMed
    13. Nakamura M, Abrouk M, Farahnik B, Zhu TH, Bhutani T. Psoriasis treatment in HIV-positive patients: a systematic review of systemic immunosuppressive therapies. Cutis. 2018 Jan; 101(1):38;42;56. PMID: 29529104.
      View in: PubMed
    14. No DJ, Amin M, Bhutani T, Wu JJ. A systematic review of active comparator controlled clinical trials in patients with moderate-to-severe psoriasis. J Dermatolog Treat. 2018 Aug; 29(5):467-474. PMID: 29103334.
      View in: PubMed
    15. Sekhon S, Jeon C, Nakamura M, Yan D, Afifi L, Bhutani T, Levin E. Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis. Psoriasis (Auckl). 2017; 7:65-72. PMID: 29387609.
      View in: PubMed
    16. Amin M, Darji K, No DJ, Bhutani T, Wu JJ. Review of IL-17 inhibitors for psoriasis. J Dermatolog Treat. 2017 Nov 10; 1-6. PMID: 29058501.
      View in: PubMed
    17. Jeon C, Nakamura M, Sekhon S, Yan D, Wu JJ, Liao W, Bhutani T. Generalized pustular psoriasis treated with apremilast in a patient with multiple medical comorbidities. JAAD Case Rep. 2017 Nov; 3(6):495-497. PMID: 29034298.
      View in: PubMed
    18. Jeon C, Sekhon S, Yan D, Afifi L, Nakamura M, Bhutani T. Monoclonal antibodies inhibiting IL-12, -23, and -17 for the treatment of psoriasis. Hum Vaccin Immunother. 2017 10 03; 13(10):2247-2259. PMID: 28825875.
      View in: PubMed
    19. Sekhon S, Jeon C, Nakamura M, Afifi L, Yan D, Wu JJ, Liao W, Bhutani T. Review of the mechanism of action of coal tar in psoriasis. J Dermatolog Treat. 2018 May; 29(3):230-232. PMID: 28814117.
      View in: PubMed
    20. Koo J, Marangell LB, Nakamura M, Armstrong A, Jeon C, Bhutani T, Wu JJ. Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression. J Eur Acad Dermatol Venereol. 2017 Dec; 31(12):1999-2009. PMID: 28681405.
      View in: PubMed
    21. Bhutani T, Abrouk M, Sima CS, Sadetsky N, Hou J, Caro I, Chren MM, Arron ST. Risk of cutaneous squamous cell carcinoma after treatment of basal cell carcinoma with vismodegib. J Am Acad Dermatol. 2017 Oct; 77(4):713-718. PMID: 28780365.
      View in: PubMed
    22. Jeon C, Yan D, Nakamura M, Sekhon S, Bhutani T, Berger T, Liao W. Frequency and Management of Sleep Disturbance in Adults with Atopic Dermatitis: A Systematic Review. Dermatol Ther (Heidelb). 2017 Sep; 7(3):349-364. PMID: 28707054.
      View in: PubMed
    23. Abrouk M, Farahnik B, Zhu TH, Nakamura M, Singh R, Lee K, Lucking SM, Blossom J, Liao W, Koo J, Bhutani T, Shinkai K, Nguyen T. Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses. J Am Acad Dermatol. 2017 07; 77(1):177-180. PMID: 28619562.
      View in: PubMed
    24. Nakamura M, Abrouk M, Zhu H, Farahnik B, Koo J, Bhutani T. Update on the Systemic Risks of Superpotent Topical Steroids. J Drugs Dermatol. 2017 Jul 01; 16(7):643-648. PMID: 28697215.
      View in: PubMed
    25. Abrouk M, Gandy J, Nakamura M, Lee K, Brodsky M, Singh R, Zhu H, Farahnik B, Bhutani T, Koo J. Secukinumab in the Treatment of Psoriasis and Psoriatic Arthritis: A Review of the Literature. Skin Therapy Lett. 2017 07; 22(4):1-6. PMID: 28732152.
      View in: PubMed
    26. Nakamura M, Lee K, Jeon C, Sekhon S, Afifi L, Yan D, Lee K, Bhutani T. Guselkumab for the Treatment of Psoriasis: A Review of Phase III Trials. Dermatol Ther (Heidelb). 2017 Sep; 7(3):281-292. PMID: 28639011.
      View in: PubMed
    27. Koo K, Jeon C, Bhutani T. Beyond monotherapy: a systematic review on creative strategies in topical therapy of psoriasis. J Dermatolog Treat. 2017 Dec; 28(8):702-708. PMID: 28481664.
      View in: PubMed
    28. Farahnik B, Beroukhim K, Nakamura M, Abrouk M, Zhu TH, Singh R, Lee K, Bhutani T, Koo J, Liao W. Use of an oral phosphodiesterase-4 inhibitor (apremilast) for the treatment of chronic, severe atopic dermatitis: a case report. Dermatol Online J. 2017 May 15; 23(5). PMID: 28537861.
      View in: PubMed
    29. Singh RK, Chang HW, Yan D, Lee KM, Ucmak D, Wong K, Abrouk M, Farahnik B, Nakamura M, Zhu TH, Bhutani T, Liao W. Influence of diet on the gut microbiome and implications for human health. J Transl Med. 2017 04 08; 15(1):73. PMID: 28388917.
      View in: PubMed
    30. Yu WY, Bhutani T, Kornik R, Pincus LB, Mauro T, Rosenblum MD, Fox LP. Warfarin-Associated Nonuremic Calciphylaxis. JAMA Dermatol. 2017 03 01; 153(3):309-314. PMID: 28099971.
      View in: PubMed
    31. Abrouk M, Beroukhim K, Nakamura M, Zhu TH, Farahnik B, Singh R, Lee K, Koo J, Bhutani T. Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule. Int J Womens Dermatol. 2017 Mar; 3(1 Suppl):S67-S69. PMID: 28492043.
      View in: PubMed
    32. Abrouk M, Nakamura M, Zhu TH, Farahnik B, Koo J, Bhutani T. The impact of PASI 75 and PASI 90 on quality of life in moderate to severe psoriasis patients. J Dermatolog Treat. 2017 Sep; 28(6):488-491. PMID: 28042711.
      View in: PubMed
    33. Abrouk M, Levin E, Brodsky M, Gandy JR, Nakamura M, Zhu TH, Farahnik B, Koo J, Bhutani T. Excimer laser for the treatment of psoriasis: safety, efficacy, and patient acceptability. Psoriasis (Auckl). 2016; 6:165-173. PMID: 29387603.
      View in: PubMed
    34. Farahnik B, Beroukhim K, Danesh M, Nakamura M, Abrouk M, Zhu TH, Singh R, Lee K, Bhutani T, Koo J. Successful use of a modified Goeckerman regimen in the treatment of chronic severe atopic dermatitis: A prospective pilot study. J Am Acad Dermatol. 2016 Nov; 75(5):1068-1071. PMID: 27745637.
      View in: PubMed
    35. Zhu TH, Nakamura M, Farahnik B, Abrouk M, Reichenberg J, Bhutani T, Koo J. Obsessive-compulsive skin disorders: a novel classification based on degree of insight. J Dermatolog Treat. 2017 Jun; 28(4):342-346. PMID: 27658538.
      View in: PubMed
    36. Nakamura M, Lee K, Singh R, Zhu TH, Farahnik B, Abrouk M, Koo J, Bhutani T. Eczema as an adverse effect of anti-TNFa therapy in psoriasis and other Th1-mediated diseases: a review. J Dermatolog Treat. 2017 May; 28(3):237-241. PMID: 27571340.
      View in: PubMed
    37. Nakamura M, Koo J, Bhutani T. Uremic pruritus treated successfully with the Goeckerman Program. Dermatol Online J. 2016 Aug 15; 22(8). PMID: 27617950.
      View in: PubMed
    38. Singh RK, Lee KM, Jose MV, Nakamura M, Ucmak D, Farahnik B, Abrouk M, Zhu TH, Bhutani T, Liao W. The Patient's Guide to Psoriasis Treatment. Part 1: UVB Phototherapy. Dermatol Ther (Heidelb). 2016 Sep; 6(3):307-13. PMID: 27474029; PMCID: PMC4972735.
      View in: PubMed, PubMed Central
    39. Farahnik B, Nakamura M, Singh RK, Abrouk M, Zhu TH, Lee KM, Jose MV, DaLovisio R, Koo J, Bhutani T, Liao W. The Patient's Guide to Psoriasis Treatment. Part 2: PUVA Phototherapy. Dermatol Ther (Heidelb). 2016 Sep; 6(3):315-24. PMID: 27474030; PMCID: PMC4972736.
      View in: PubMed, PubMed Central
    40. Abrouk M, Nakamura M, Zhu TH, Farahnik B, Singh RK, Lee KM, Jose MV, Koo J, Bhutani T, Liao W. The Patient's Guide to Psoriasis Treatment. Part 3: Biologic Injectables. Dermatol Ther (Heidelb). 2016 Sep; 6(3):325-31. PMID: 27474031; PMCID: PMC4972737.
      View in: PubMed, PubMed Central
    41. Zhu TH, Nakamura M, Farahnik B, Abrouk M, Singh RK, Lee KM, Hulse S, Koo J, Bhutani T, Liao W. The Patient's Guide to Psoriasis Treatment. Part 4: Goeckerman Therapy. Dermatol Ther (Heidelb). 2016 Sep; 6(3):333-9. PMID: 27474032; PMCID: PMC4972738.
      View in: PubMed, PubMed Central
    42. Farahnik B, Patel V, Beroukhim K, Zhu TH, Abrouk M, Nakamura M, Singh R, Lee K, Bhutani T, Koo J. Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability. Psoriasis (Auckl). 2016; 6:105-111. PMID: 29387597.
      View in: PubMed
    43. Nakamura M, Farahnik B, Bhutani T. Recent advances in phototherapy for psoriasis. F1000Res. 2016; 5. PMID: 27499849; PMCID: PMC4946393.
      View in: PubMed, PubMed Central
    44. Nakamura M, Bhutani T, Koo JY. Narrowband UVB-induced iatrogenic polymorphous light eruption: a case and suggestions to overcome this rare complication. Dermatol Online J. 2016 Jun 15; 22(6). PMID: 27617609.
      View in: PubMed
    45. Zhu TH, Nakamura M, Farahnik B, Abrouk M, Lee K, Singh R, Gevorgyan A, Koo J, Bhutani T. The Role of the Nervous System in the Pathophysiology of Psoriasis: A Review of Cases of Psoriasis Remission or Improvement Following Denervation Injury. Am J Clin Dermatol. 2016 Jun; 17(3):257-63. PMID: 26935938.
      View in: PubMed
    46. Farahnik B, Beroukhim K, Abrouk M, Nakamura M, Zhu TH, Singh R, Lee K, Bhutani T, Koo J. Brodalumab for the Treatment of Psoriasis: A Review of Phase III Trials. Dermatol Ther (Heidelb). 2016 Jun; 6(2):111-24. PMID: 27221323; PMCID: PMC4906115.
      View in: PubMed, PubMed Central
    47. Abrouk M, Beroukhim K, Nakamura M, Zhu TH, Farahnik B, Singh R, Brodsky M, Lee K, Koo J, Bhutani T. Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule. Int J Womens Dermatol. 2016 Jun; 2(2):62-64. PMID: 28492009.
      View in: PubMed
    48. Farahnik B, Beroukhim K, Nakamura M, Abrouk M, Zhu TH, Singh R, Lee K, Bhutani T, Koo J. Anti-IL-17 Agents for Psoriasis: A Review of Phase III Data. J Drugs Dermatol. 2016 Mar; 15(3):311-6. PMID: 26954316.
      View in: PubMed
    49. Farahnik B, Beroukhim K, Zhu TH, Abrouk M, Nakamura M, Singh R, Lee K, Bhutani T, Koo J. Ixekizumab for the Treatment of Psoriasis: A Review of Phase III Trials. Dermatol Ther (Heidelb). 2016 Mar; 6(1):25-37. PMID: 26910853; PMCID: PMC4799032.
      View in: PubMed, PubMed Central
    50. Zhu TH, Nakamura M, Abrouk M, Farahnik B, Koo J, Bhutani T. Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review. J Dermatolog Treat. 2016 Oct; 27(5):406-13. PMID: 26837667.
      View in: PubMed
    51. Singh RK, Lee KM, Vujkovic-Cvijin I, Ucmak D, Farahnik B, Abrouk M, Nakamura M, Zhu TH, Bhutani T, Wei M, Liao W. The role of IL-17 in vitiligo: A review. Autoimmun Rev. 2016 Apr; 15(4):397-404. PMID: 26804758; PMCID: PMC4769658 [Available on 04/01/17].
      View in: PubMed, PubMed Central
    52. Yu WY, Manrriquez E, Bhutani T, Chaganti RK, Ruben BS, Schwartz BS, Fox LP. Sweet heart: A case of pregnancy-associated acute febrile neutrophilic dermatosis with myopericarditis. JAAD Case Rep. 2015 Jan; 1(1):12-4. PMID: 27075127; PMCID: PMC4802522.
      View in: PubMed, PubMed Central
    53. Tartar D, Bhutani T, Huynh M, Berger T, Koo J. Update on the immunological mechanism of action behind phototherapy. J Drugs Dermatol. 2014 May; 13(5):564-8. PMID: 24809879.
      View in: PubMed
    54. Fitzmaurice S, Bhutani T, Koo J. Goeckerman regimen for management of psoriasis refractory to biologic therapy: the University of California San Francisco experience. J Am Acad Dermatol. 2013 Oct; 69(4):648-9. PMID: 24034372.
      View in: PubMed
    55. Bhutani T, Wong JW, Bebo BF, Armstrong AW. Access to health care in patients with psoriasis and psoriatic arthritis: data from National Psoriasis Foundation survey panels. JAMA Dermatol. 2013 Jun; 149(6):717-21. PMID: 23783152.
      View in: PubMed
    56. Ladizinski B, Heller MM, Bhutani T, Zitelli KB, Koo JY. Progressive multifocal leukoencephalopathy and reversible progressive leukoencephalopathy syndrome in dermatologic therapy. J Drugs Dermatol. 2013 Feb; 12(2):e20-4. PMID: 23377400.
      View in: PubMed
    57. Bhutani T, Patel T, Koo B, Nguyen T, Hong J, Koo J. A prospective, interventional assessment of psoriasis quality of life using a nonskin-specific validated instrument that allows comparison with other major medical conditions. J Am Acad Dermatol. 2013 Aug; 69(2):e79-88. PMID: 23207011.
      View in: PubMed
    58. Wong JW, Nguyen TV, Bhutani T, Koo JY. Treatment of psoriasis and long-term maintenance using 308 nm excimer laser, clobetasol spray, and calcitriol ointment: a case series. J Drugs Dermatol. 2012 Aug; 11(8):994-6. PMID: 22859247.
      View in: PubMed
    59. Bhutani T, Kamangar F, Zitelli K, Chiang C, Gattu S, Nguyen T, Becker E, Koo J. Intralesional injections of alefacept may predict systemic response to intramuscular alefacept: results from a pilot study. J Dermatolog Treat. 2013 Oct; 24(5):348-50. PMID: 22506829.
      View in: PubMed
    60. Heller MM, Wong JW, Nguyen TV, Lee ES, Bhutani T, Menter A, Koo JY. Quality-of-life instruments: evaluation of the impact of psoriasis on patients. Dermatol Clin. 2012 Apr; 30(2):281-91, ix. PMID: 22284142.
      View in: PubMed
    61. Kamangar F, Koo J, Heller M, Lee E, Bhutani T. Oral vitamin D, still a viable treatment option for psoriasis. J Dermatolog Treat. 2013 Aug; 24(4):261-7. PMID: 22103655.
      View in: PubMed
    62. Bhutani T, Kamangar F, Cordoro KM. Management of pediatric psoriasis. Pediatr Ann. 2012 Jan 13; 41(1):e1-7. PMID: 22224488.
      View in: PubMed
    63. Keaney TC, Bhutani T, Sivanesan P, Bandow GD, Weinstein SB, Cheung LC, Malick F, Koo J. Open-label, pilot study examining sequential therapy with oral tacrolimus and topical tacrolimus for severe atopic dermatitis. J Am Acad Dermatol. 2012 Oct; 67(4):636-41. PMID: 22221776.
      View in: PubMed
    64. Kamangar F, Isip L, Bhutani T, Dennis M, Heller MM, Lee ES, Nie H, Liao W. How psoriasis patients perceive, obtain, and use biologic agents: Survey from an academic medical center. J Dermatolog Treat. 2013 Feb; 24(1):13-24. PMID: 22007699; PMCID: PMC3679890.
      View in: PubMed, PubMed Central
    65. Bhutani T, Koo J. A review of the chemopreventative effects of oral retinoids for internal neoplasms. J Drugs Dermatol. 2011 Nov; 10(11):1292-8. PMID: 22052311.
      View in: PubMed
    66. Patel T, Bhutani T, Busse KL, Koo J. Evaluating the efficacy and safety of calcipotriene/betamethasone ointment occluded with a hydrogel patch: a 6-week bilaterally controlled, investigator-blinded trial. Cutis. 2011 Sep; 88(3):149-54. PMID: 22017069.
      View in: PubMed
    67. Dennis M, Bhutani T, Koo J, Liao W. Goeckerman therapy for the treatment of eczema: a practical guide and review of efficacy. J Dermatolog Treat. 2013 Feb; 24(1):2-6. PMID: 21797807; PMCID: PMC3678985.
      View in: PubMed, PubMed Central
    68. Haddican MM, Bhutani T, McClelland PB, Koo JYM. Why are there significant differences in published narrowband ultraviolet B dosimetry recommendations? The need for national standardization of phototherapy treatment. J Am Acad Dermatol. 2011 Aug; 65(2):411-414. PMID: 21763563.
      View in: PubMed
    69. Bhutani T, Zitelli KB, Koo J. Yin-yang strategy: proposing a new, effective, repeatable, sequential therapy for psoriasis. J Drugs Dermatol. 2011 Aug; 10(8):831-4. PMID: 21818503.
      View in: PubMed
    70. Park KK, Kamangar F, Heller M, Lee E, Bhutani T, Busse K, Patel T, Koo J. Instant barrier repair: A pilot study investigating occlusion with a new hydrogel patch for the treatment of atopic dermatitis. J Dermatolog Treat. 2013 Apr; 24(2):119-21. PMID: 21801112.
      View in: PubMed
    71. Bhutani T, Koo J, Maibach HI. Efficacy of clobetasol spray: factors beyond patient compliance. J Dermatolog Treat. 2012 Feb; 23(1):11-5. PMID: 21254848.
      View in: PubMed
    72. Gattu S, Busse K, Bhutani T, Chiang C, Nguyen T, Becker E, Koo JY. Psoriasis responds to intralesional injections of alefacept and may predict systemic response to intramuscular alefacept: interim results of a single-arm, open-label study. J Dermatolog Treat. 2012 Apr; 23(2):103-8. PMID: 21254875.
      View in: PubMed
    73. Ladizinski B, Busse KL, Bhutani T, Koo JY. Aripiprazole as a viable alternative for treating delusions of parasitosis. J Drugs Dermatol. 2010 Dec; 9(12):1531-2. PMID: 21120263.
      View in: PubMed
    74. Bhutani T, Liao W. A Practical Approach to Home UVB Phototherapy for the Treatment of Generalized Psoriasis. Pract Dermatol. 2010 Aug; 7(2):31-35. PMID: 25191138.
      View in: PubMed
    75. Bhutani T, Koo J. Paradoxical worsening of psoriasis when switching from etanercept to adalimumab: a case series. J Dermatolog Treat. 2011 Apr; 22(2):75-8. PMID: 20524874.
      View in: PubMed
    76. Reinstadler A, Mau N, Bhutani T, Talkin B, Yamauchi P, Chiu M, Peng D. Perioperative use of anti-tumor necrosis factor-alfa agents. J Am Acad Dermatol. 2010 Jan; 62(1):154-5. PMID: 20082898.
      View in: PubMed
    77. Maier LE, Lampel HP, Bhutani T, Jacob SE. Hand dermatitis: a focus on allergic contact dermatitis to biocides. Dermatol Clin. 2009 Jul; 27(3):251-64, v-vi. PMID: 19580920.
      View in: PubMed
    78. Bhutani T, Peng D, Shin T, Lee H. Common sources of skin care education: a cross-sectional study. Int J Dermatol. 2009 May; 48(5):506-12. PMID: 19416382.
      View in: PubMed
    79. Bhutani T, Jacob SE. Triclosan: a potential allergen in suture-line allergic contact dermatitis. Dermatol Surg. 2009 May; 35(5):888-9. PMID: 19389086.
      View in: PubMed
    Tina's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (242) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (24) people
    _
    Similar People
    People who share similar concepts with this person.
    See all (60) people
    _
    Same Department
    Search Department
    ↑